These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32323609)

  • 1. Phase I/II Study of Intrathecal Administration of Recombinant Human Hepatocyte Growth Factor in Patients with Acute Spinal Cord Injury: A Double-Blind, Randomized Clinical Trial of Safety and Efficacy.
    Nagoshi N; Tsuji O; Kitamura K; Suda K; Maeda T; Yato Y; Abe T; Hayata D; Matsumoto M; Okano H; Nakamura M
    J Neurotrauma; 2020 Aug; 37(15):1752-1758. PubMed ID: 32323609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte-colony stimulating factor administration for neurological improvement in patients with postrehabilitation chronic incomplete traumatic spinal cord injuries: a double-blind randomized controlled clinical trial.
    Derakhshanrad N; Saberi H; Yekaninejad MS; Joghataei MT; Sheikhrezaei A
    J Neurosurg Spine; 2018 Jul; 29(1):97-107. PubMed ID: 29701561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of granulocyte colony-stimulating factor for spinal cord injury.
    Koda M; Hanaoka H; Fujii Y; Hanawa M; Kawasaki Y; Ozawa Y; Fujiwara T; Furuya T; Ijima Y; Saito J; Kitamura M; Miyamoto T; Ohtori S; Matsumoto Y; Abe T; Takahashi H; Watanabe K; Hirano T; Ohashi M; Shoji H; Mizouchi T; Kawahara N; Kawaguchi M; Orita Y; Sasamoto T; Yoshioka M; Fujii M; Yonezawa K; Soma D; Taneichi H; Takeuchi D; Inami S; Moridaira H; Ueda H; Asano F; Shibao Y; Aita I; Takeuchi Y; Mimura M; Shimbo J; Someya Y; Ikenoue S; Sameda H; Takase K; Ikeda Y; Nakajima F; Hashimoto M; Hasue F; Fujiyoshi T; Kamiya K; Watanabe M; Katoh H; Matsuyama Y; Hasegawa T; Yoshida G; Arima H; Yamato Y; Oe S; Togawa D; Kobayashi S; Akeda K; Kawamoto E; Imai H; Sakakibara T; Sudo A; Ito Y; Kikuchi T; Takigawa T; Morita T; Tanaka N; Nakanishi K; Kamei N; Kotaka S; Baba H; Okudaira T; Konishi H; Yamaguchi T; Ito K; Katayama Y; Matsumoto T; Matsumoto T; Kanno H; Aizawa T; Hashimoto K; Eto T; Sugaya T; Matsuda M; Fushimi K; Nozawa S; Iwai C; Taguchi T; Kanchiku T; Suzuki H; Nishida N; Funaba M; Sakai T; Imajo Y; Yamazaki M
    Brain; 2021 Apr; 144(3):789-799. PubMed ID: 33764445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety, Tolerability, and Pharmacodynamics of Intrathecal Injection of Recombinant Human HGF (KP-100) in Subjects With Amyotrophic Lateral Sclerosis: A Phase I Trial.
    Warita H; Kato M; Asada R; Yamashita A; Hayata D; Adachi K; Aoki M
    J Clin Pharmacol; 2019 May; 59(5):677-687. PubMed ID: 30536581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury.
    Casha S; Zygun D; McGowan MD; Bains I; Yong VW; Hurlbert RJ
    Brain; 2012 Apr; 135(Pt 4):1224-36. PubMed ID: 22505632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of Hepatocyte Growth Factor for Acute Spinal Cord Injury: The Road from Basic Studies to Human Treatment.
    Kitamura K; Nagoshi N; Tsuji O; Matsumoto M; Okano H; Nakamura M
    Int J Mol Sci; 2019 Feb; 20(5):. PubMed ID: 30823442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological and functional status 1 year after acute spinal cord injury: estimates of functional recovery in National Acute Spinal Cord Injury Study II from results modeled in National Acute Spinal Cord Injury Study III.
    Bracken MB; Holford TR
    J Neurosurg; 2002 Apr; 96(3 Suppl):259-66. PubMed ID: 11990832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter prospective nonrandomized controlled clinical trial to prove neurotherapeutic effects of granulocyte colony-stimulating factor for acute spinal cord injury: analyses of follow-up cases after at least 1 year.
    Inada T; Takahashi H; Yamazaki M; Okawa A; Sakuma T; Kato K; Hashimoto M; Hayashi K; Furuya T; Fujiyoshi T; Kawabe J; Mannoji C; Miyashita T; Kadota R; Someya Y; Ikeda O; Hashimoto M; Suda K; Kajino T; Ueda H; Ito Y; Ueta T; Hanaoka H; Takahashi K; Koda M
    Spine (Phila Pa 1976); 2014 Feb; 39(3):213-9. PubMed ID: 24299727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study protocol for the G-SPIRIT trial: a randomised, placebo-controlled, double-blinded phase III trial of granulocyte colony-stimulating factor-mediated neuroprotection for acute spinal cord injury.
    Koda M; Hanaoka H; Sato T; Fujii Y; Hanawa M; Takahashi S; Furuya T; Ijima Y; Saito J; Kitamura M; Ohtori S; Matsumoto Y; Abe T; Watanabe K; Hirano T; Ohashi M; Shoji H; Mizouchi T; Takahashi I; Kawahara N; Kawaguchi M; Orita Y; Sasamoto T; Yoshioka M; Fujii M; Yonezawa K; Soma D; Taneichi H; Takeuchi D; Inami S; Moridaira H; Ueda H; Asano F; Shibao Y; Aita I; Takeuchi Y; Mimura M; Shimbo J; Someya Y; Ikenoue S; Sameda H; Takase K; Ikeda Y; Nakajima F; Hashimoto M; Ozawa T; Hasue F; Fujiyoshi T; Kamiya K; Watanabe M; Katoh H; Matsuyama Y; Yamamoto Y; Togawa D; Hasegawa T; Kobayashi S; Yoshida G; Oe S; Banno T; Arima H; Akeda K; Kawamoto E; Imai H; Sakakibara T; Sudo A; Ito Y; Kikuchi T; Osaki S; Tanaka N; Nakanishi K; Kamei N; Kotaka S; Baba H; Okudaira T; Konishi H; Yamaguchi T; Ito K; Katayama Y; Matsumoto T; Matsumoto T; Idota M; Kanno H; Aizawa T; Hashimoto K; Eto T; Sugaya T; Matsuda M; Fushimi K; Nozawa S; Iwai C; Taguchi T; Kanchiku T; Suzuki H; Nishida N; Funaba M; Yamazaki M
    BMJ Open; 2018 May; 8(5):e019083. PubMed ID: 29730616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized Controlled Trial of Local Delivery of a Rho Inhibitor (VX-210) in Patients with Acute Traumatic Cervical Spinal Cord Injury.
    Fehlings MG; Chen Y; Aarabi B; Ahmad F; Anderson KD; Dumont T; Fourney DR; Harrop JS; Kim KD; Kwon BK; Lingam HK; Rizzo M; Shih LC; Tsai EC; Vaccaro A; McKerracher L
    J Neurotrauma; 2021 Aug; 38(15):2065-2072. PubMed ID: 33559524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human hepatocyte growth factor promotes functional recovery in primates after spinal cord injury.
    Kitamura K; Fujiyoshi K; Yamane J; Toyota F; Hikishima K; Nomura T; Funakoshi H; Nakamura T; Aoki M; Toyama Y; Okano H; Nakamura M
    PLoS One; 2011; 6(11):e27706. PubMed ID: 22140459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of neurological and functional outcomes after administration of granulocyte-colony-stimulating factor in motor-complete versus motor-incomplete postrehabilitated, chronic spinal cord injuries: a phase I/II study.
    Saberi H; Derakhshanrad N; Yekaninejad MS
    Cell Transplant; 2014; 23 Suppl 1():S19-23. PubMed ID: 25302604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-in-Man Intrathecal Application of Neurite Growth-Promoting Anti-Nogo-A Antibodies in Acute Spinal Cord Injury.
    Kucher K; Johns D; Maier D; Abel R; Badke A; Baron H; Thietje R; Casha S; Meindl R; Gomez-Mancilla B; Pfister C; Rupp R; Weidner N; Mir A; Schwab ME; Curt A
    Neurorehabil Neural Repair; 2018 Jun; 32(6-7):578-589. PubMed ID: 29869587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rho Inhibitor VX-210 in Acute Traumatic Subaxial Cervical Spinal Cord Injury: Design of the SPinal Cord Injury Rho INhibition InvestiGation (SPRING) Clinical Trial.
    Fehlings MG; Kim KD; Aarabi B; Rizzo M; Bond LM; McKerracher L; Vaccaro AR; Okonkwo DO
    J Neurotrauma; 2018 May; 35(9):1049-1056. PubMed ID: 29316845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale, design and critical end points for the Riluzole in Acute Spinal Cord Injury Study (RISCIS): a randomized, double-blinded, placebo-controlled parallel multi-center trial.
    Fehlings MG; Nakashima H; Nagoshi N; Chow DS; Grossman RG; Kopjar B
    Spinal Cord; 2016 Jan; 54(1):8-15. PubMed ID: 26099215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I/IIa clinical trial of a recombinant Rho protein antagonist in acute spinal cord injury.
    Fehlings MG; Theodore N; Harrop J; Maurais G; Kuntz C; Shaffrey CI; Kwon BK; Chapman J; Yee A; Tighe A; McKerracher L
    J Neurotrauma; 2011 May; 28(5):787-96. PubMed ID: 21381984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective Effects of Direct Intrathecal Administration of Granulocyte Colony-Stimulating Factor in Rats with Spinal Cord Injury.
    Chen WF; Chen CH; Chen NF; Sung CS; Wen ZH
    CNS Neurosci Ther; 2015 Sep; 21(9):698-707. PubMed ID: 26190345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human NgR-Fc decoy protein via lumbar intrathecal bolus administration enhances recovery from rat spinal cord contusion.
    Wang X; Yigitkanli K; Kim CY; Sekine-Komo T; Wirak D; Frieden E; Bhargava A; Maynard G; Cafferty WB; Strittmatter SM
    J Neurotrauma; 2014 Dec; 31(24):1955-66. PubMed ID: 24964223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal pressure monitoring and cerebrospinal fluid drainage in acute spinal cord injury: a prospective randomized trial.
    Kwon BK; Curt A; Belanger LM; Bernardo A; Chan D; Markez JA; Gorelik S; Slobogean GP; Umedaly H; Giffin M; Nikolakis MA; Street J; Boyd MC; Paquette S; Fisher CG; Dvorak MF
    J Neurosurg Spine; 2009 Mar; 10(3):181-93. PubMed ID: 19320576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte growth factor promotes endogenous repair and functional recovery after spinal cord injury.
    Kitamura K; Iwanami A; Nakamura M; Yamane J; Watanabe K; Suzuki Y; Miyazawa D; Shibata S; Funakoshi H; Miyatake S; Coffin RS; Nakamura T; Toyama Y; Okano H
    J Neurosci Res; 2007 Aug; 85(11):2332-42. PubMed ID: 17549731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.